Modena, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 545
NA - Nord America 454
AS - Asia 222
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.224
Nazione #
US - Stati Uniti d'America 453
GB - Regno Unito 229
CN - Cina 137
SG - Singapore 67
SE - Svezia 66
DE - Germania 48
IT - Italia 45
IE - Irlanda 43
RU - Federazione Russa 43
FR - Francia 32
FI - Finlandia 23
VN - Vietnam 5
UA - Ucraina 4
BE - Belgio 3
PH - Filippine 3
BD - Bangladesh 2
CH - Svizzera 2
EU - Europa 2
LK - Sri Lanka 2
NL - Olanda 2
PL - Polonia 2
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
CA - Canada 1
GR - Grecia 1
ID - Indonesia 1
IN - India 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
TR - Turchia 1
Totale 1.224
Città #
Southend 223
Chandler 113
Woodbridge 90
Singapore 59
Dublin 43
Beijing 29
Ann Arbor 27
Ashburn 24
Houston 21
Jacksonville 16
Lawrence 14
Princeton 14
Nanjing 13
Verona 12
New York 9
Wilmington 9
Jinan 8
Haikou 6
Hebei 6
Sindelfingen 6
Bologna 5
Redwood City 5
Shenyang 5
Zhengzhou 5
Changsha 4
Guangzhou 4
Helsinki 4
Taizhou 4
Brussels 3
Dearborn 3
Detroit 3
Fuzhou 3
Norwalk 3
Colombo 2
Dallas 2
Dhaka 2
Frankfurt am Main 2
Groningen 2
Jiaxing 2
Lanzhou 2
Lausanne 2
Los Angeles 2
Moscow 2
Ningbo 2
Nürnberg 2
Rome 2
Taiyuan 2
Trento 2
Athens 1
Austin 1
Baku 1
Bergamo 1
Bishkek 1
Chaoyang 1
Clifton 1
Dong Ket 1
Hangzhou 1
Hefei 1
Jakarta 1
Kemerovo 1
Kochi 1
Leawood 1
Licata 1
London 1
Manila 1
Markham 1
Milan 1
Nanchang 1
Ospedaletto Euganeo 1
Pavia 1
Rochester 1
Saarbrücken 1
Santa Clara 1
Seattle 1
Stockholm 1
São Paulo 1
Tianjin 1
Vienna 1
Yongzhou 1
Totale 854
Nome #
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 111
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 106
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 106
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 104
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 103
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 93
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 93
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice 92
The route to personalized medicine in bladder cancer: where do we stand? 86
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 85
AR-V7 and prostate cancer: The watershed for treatment selection? 83
Metabolic alterations in renal cell carcinoma 75
Metabolic Alterations in Renal and Prostate Cancer 59
Kidney cancer and 2014: is innovation really over? 55
Totale 1.251
Categoria #
all - tutte 4.346
article - articoli 4.346
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 0 19 29 7 5 4 5 12
2020/202183 10 16 3 16 10 8 6 0 1 1 6 6
2021/202297 8 17 0 18 8 5 2 4 6 0 4 25
2022/2023278 18 33 23 49 23 67 0 26 29 2 7 1
2023/2024102 6 6 10 10 23 9 2 11 3 3 18 1
2024/2025162 17 20 26 80 5 14 0 0 0 0 0 0
Totale 1.251